Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10658)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Apr 14, 2017 (publication date) through Nov 4, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Mayr C, Ocker M, Ritter M, Pichler M, Neureiter D, Kiesslich T. Biliary tract cancer stem cells - translational options and challenges. World J Gastroenterol 2017; 23(14): 2470-2482 [PMID: 28465631 DOI: 10.3748/wjg.v23.i14.2470] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i14/2470.htm |
| Number | Citing Articles |
| 1 |
Akitada Yogo, Toshihiko Masui, Shigeo Takaishi, Kenji Masuo, Ru Chen, Yosuke Kasai, Kazuyuki Nagai, Takayuki Anazawa, Sadanori Watanabe, Satoko Sakamoto, Akira Watanabe, Ryosaku Inagaki, Masahiro M. Nakagawa, Seishi Ogawa, Hiroshi Seno, Shinji Uemoto, Etsuro Hatano. Inhibition of dopamine receptor D1 signaling promotes human bile duct cancer progression via WNT signaling. Cancer Science 2023; 114(4): 1324 doi: 10.1111/cas.15676
|
| 2 |
Daniel Neureiter, Tobias Kiesslich, Markus Ritter, Christian Mayr. Update on the role and therapeutic potential of polycomb repressive complexes in (biliary tract) cancer. Expert Opinion on Therapeutic Targets 2018; 22(1): 1 doi: 10.1080/14728222.2018.1406923
|
| 3 |
Alessandro Rizzo, Giovanni Brandi. First-line Chemotherapy in Advanced Biliary Tract Cancer Ten Years After the ABC-02 Trial: “And Yet It Moves!”. Cancer Treatment and Research Communications 2021; 27: 100335 doi: 10.1016/j.ctarc.2021.100335
|
| 4 |
Christian Mayr, Tobias Kiesslich, Dominik Paul Modest, Sebastian Stintzing, Matthias Ocker, Daniel Neureiter. Chemoresistance and resistance to targeted therapies in biliary tract cancer: what have we learned?. Expert Opinion on Investigational Drugs 2022; 31(2): 221 doi: 10.1080/13543784.2022.2034785
|
| 5 |
Vittorio Branchi, Benedict Jürgensen, Laura Esser, Maria Gonzalez-Carmona, Tobias J. Weismüller, Christian P. Strassburg, Jonas Henn, Alexander Semaan, Philipp Lingohr, Steffen Manekeller, Glen Kristiansen, Jörg C. Kalff, Marieta I. Toma, Hanno Matthaei. Tumor Infiltrating Neutrophils Are Frequently Found in Adenocarcinomas of the Biliary Tract and Their Precursor Lesions with Possible Impact on Prognosis. Journal of Personalized Medicine 2021; 11(3): 233 doi: 10.3390/jpm11030233
|
| 6 |
Watcharin Loilome, Hasaya Dokduang, Manida Suksawat, Sureerat Padthaisong. Therapeutic challenges at the preclinical level for targeted drug development for Opisthorchis viverrini-associated cholangiocarcinoma. Expert Opinion on Investigational Drugs 2021; 30(9): 985 doi: 10.1080/13543784.2021.1955102
|
| 7 |
Soo Young Cho, Heeyoun Hwang, Yun-Hee Kim, Byong Chul Yoo, Nayoung Han, Sun-Young Kong, Min-Jeong Baek, Kyung-Hee Kim, Mi Rim Lee, Jae Gwang Park, Sung-Sik Han, Woo Jin Lee, Charny Park, Jong Bae Park, Jin Young Kim, Sang-Jae Park, Sang Myung Woo. Refining Classification of Cholangiocarcinoma Subtypes via Proteogenomic Integration Reveals New Therapeutic Prospects. Gastroenterology 2023; 164(7): 1293 doi: 10.1053/j.gastro.2023.02.045
|
| 8 |
Marlena Beyreis, Martin Gaisberger, Martin Jakab, Daniel Neureiter, Katharina Helm, Markus Ritter, Tobias Kiesslich, Christian Mayr. The Cancer Stem Cell Inhibitor Napabucasin (BBI608) Shows General Cytotoxicity in Biliary Tract Cancer Cells and Reduces Cancer Stem Cell Characteristics. Cancers 2019; 11(3): 276 doi: 10.3390/cancers11030276
|
| 9 |
Fei Zhou, Yanhua Zhang, Jihong Sun, Xiaoming Yang. Characteristics of a novel cell line ZJU-0430 established from human gallbladder carcinoma. Cancer Cell International 2019; 19(1) doi: 10.1186/s12935-019-0911-1
|
| 10 |
Sureerat Padthaisong, Malinee Thanee, Nisana Namwat, Jutarop Phetcharaburanin, Poramate Klanrit, Narong Khuntikeo, Attapol Titapun, Sakkarn Sungkhamanon, Hideyuki Saya, Watcharin Loilome. Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma. Journal of Translational Medicine 2020; 18(1) doi: 10.1186/s12967-020-02243-w
|
| 11 |
|
| 12 |
Dino Bekric, Daniel Neureiter, Markus Ritter, Martin Jakab, Martin Gaisberger, Martin Pichler, Tobias Kiesslich, Christian Mayr. Long Non-Coding RNAs in Biliary Tract Cancer—An Up-to-Date Review. Journal of Clinical Medicine 2020; 9(4): 1200 doi: 10.3390/jcm9041200
|